Skip To Main Content
Keren Baruch on Muck Rack

Keren Baruch

As seen in: LinkedIn, BlogHer, Social Media Today, JD Supra, Mondaq, LexBlog
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Keren

Contact Keren, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

2024 Top-of-Mind Issues for Life Sciences Companies | JD Supra

|
By Keren Baruch, Eve Costopoulos, Audrey Crowell
| JD Supra
As we reflect on 2023 and make predictions for 2024, it is remarkable the number of significant events occurring this past year that will be impactful for the activities of the life sciences industry going forward. Although there was no single moment like the passage of the Affordable Care Act in 2010, there are numerous distinct events that will loom large in 2024 and beyond. Please see full publication below for more information. Download PDF
Open in Who Shared Issue with article?

Connecticut Follows In The Footsteps Of Other Jurisdictions Requiring Registration Of Pharmaceutical Representatives

|
By Justine Lei, Keren Baruch, Phil Kim, Jeremiah Miah
| Mondaq
Connecticut is the latest state to join the efforts of jurisdictions such as Oregon, Nevada, Washington D.C., and the City of Chicago, Illinois, in further regulating the activities of pharmaceutical representatives. In June, Governor Ned Lamont signed into law "An Act Protecting Patients and Prohibiting Unnecessary Health Care Costs" (the "Act"), which imposes new registration, reporting, and disclosure requirements on pharmaceutical representatives in the State of Connecticut.
Open in Who Shared Issue with article?

Connecticut Follows in the Footsteps of Other Jurisdictions Requiring Registration of Pharmaceutical Representatives | JD Supra

|
By Keren Baruch, Dominick DiSabatino, Phil Kim
| JD Supra
[co-author: Jeremiah Miah] Connecticut is the latest state to join the efforts of jurisdictions such as Oregon, Nevada, Washington D.C., and the City of Chicago, Illinois, in further regulating the activities of pharmaceutical representatives.
Open in Who Shared Issue with article?
See all 16 articles